An impaired baroreceptor reflex sensitivity controlling the heart period through the vagus nerves (BRS) and sympatho-humoral activation following acute myocardial infarction (AMI) represent adverse prognostic indices. The occurrence of AMI in patients with hypertension (HT-AMI) is not unexpected, and has been associated with a greater mortality than that occurring in normotensive subjects (NT-AMI). This study was planned to determine whether HT-AMI patients have a greater central sympathetic output and BRS impairment than NT-AMI patients.
P-556 ␤2-AND ␤3-ADRENOCEPTOR POLYMORPHISMS ARE RELATED WITH WEIGHT GAIN AND BLOOD PRESSURE ELEVATION OVER 5 YEARS
The genes responsible for obesity are also candidate genes for obesityrelated diseases, such as hypertension. Functional polymorphisms in the ␤2-and ␤3-adrenoceptors have been reported to be associated with hypertension and obesity. To clarify the relevance of the ␤-adrenoceptor polymorphisms to weight gain, blood pressure (BP) elevation and sympathetic nerve activity, we studied their association with polymorphisms of ␤2-adrenoceptor genes (Arg16Gly, Gln27Glu) and ␤3-adrenoceptor gene (Trp64Arg). Changes in body weight, BP levels and plasma norepinephrine (NE) levels over 5 years were studied in 160 young, Japanese men, who were nonobese and normotensive at entry. The relationship of these to the ␤-adrenoceptor polymorphisms were also investigated. Significant weight gain and BP elevation were defined as Ն10% increases over 5 years in BMI or mean BP from entry. The presence of Gly allele of Arg16Gly and Arg allele of Trp64Arg were associated with higher frequencies of weight gain and BP elevation. The subjects carrying Gln allele of Gln27Glu had higher frequency of BP elevation. Significantly higher levels of plasma NE were observed in the subjects with Gly16 allele of Arg16Gly and Gln27 allele of Gln27Glu, who had higher frequency of weight gain and/or BP elevation. These results demonstrate that the polymorphisms of Arg16Gly and Trp64Arg are related with propensity for weight gain and BP elevation, and that the polymorphism of Gln27Glu is linked to BP elevation. The subjects carrying the polymorphisms linked to weight gain and BP elevation have heightened sympathetic activity prior to weight gain and BP elevation, suggesting that ␤-adrenergic receptors polymorphisms associated with heightened sympathetic nerve activity both antedates and predicts the onset of obesity and hypertension.
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P-557 INHIBITION OF NITRIC OXIDE SYNTHESIS DOES NOT ALTER HYPOGLYCEMIA-INDUCED ACTIVATION OF LUMBAR SYMPATHETIC NERVE ACTIVITY IN RATS

Martin S Muntzel, Onyekwere Onwumere, Tawyanna Joseph. Biological Sciences, Lehman College, Bronx, NY.
Several studies utilizing nitric oxide (NO) donors or inhibitors of NO synthase have shown that NO generally causes reductions in sympathetic nerve activity (SNA). For example, NO donors usually decrease SNA whereas NO synthase inhibitors produce gradual increases in sympathetic neural output. However, few studies have examined whether NO modulates reflex increases in SNA elicited by sympathoexcitatory stimuli. Given this background, we hypothesized that elevations in SNA, generated by insulin-induced hypoglycemia, would be potentiated by pretreatment with the NO synthase inhibitor, NG-monomethyl-L-arginine (L-NMMA). We administered an insulin bolus (30U/kg, i.v.) in urethaneanaesthetized rats receiving either no pretreatment (Insulin group; n ϭ 8) or after pretreatment with LNMMA (L-NMMA-Insulin group; 0.35 mg/kg/min, i.v.; n ϭ 13), while measuring blood glucose, mean arterial pressure (MAP), heart rate (HR), and lumbar SNA. We found that insulin caused equivalent blood glucose decreases in the Insulin (from 161Ϯ14 mg/dl to 63Ϯ3 mg/dl) and L-NMMA-Insulin (from 170Ϯ14 mg/dl to 58Ϯ15 mg/dl) groups. Insulin-induced hypoglycemia caused expected MAP decreases in the Insulin group (from 113Ϯ11 mmHg to 101Ϯ14 mmHg) that were abolished and reversed into elevations in the L-NMMA-Insulin group (from 106Ϯ6 mmHg to 112Ϯ7 mmHg). Hypoglycemia stimulated substantial HR increases that were not different between the Insulin (from 371Ϯ9 bpm to 428Ϯ26 bpm) and L-NMMAInsulin (from 369Ϯ10 bpm to 404Ϯ21 bpm) groups. Finally, and in contrast to our expectation, increases in SNA to hypoglycemia were not different between the Insulin (273Ϯ70 % from 100% baseline) and L-NMMA-Insulin (307Ϯ56 % from 100% baseline) groups. These findings suggest that NO does not modulate increases in lumbar SNA induced by severe hypoglycemic stress. Furthermore, our finding that MAP decreases to hypoglycemia were abolished by L-NMMA indicates that the blood pressure decreases may be secondary to epinephrineinduced activation of beta-2-adrenergic receptors as well as NO-induced vasodilation.
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